| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038298896 |
| P356 | DOI | 10.1245/S10434-012-2473-5 |
| P698 | PubMed publication ID | 23090572 |
| P50 | author | Diane Goere | Q40350292 |
| P2093 | author name string | Dominique Elias | |
| Charles Honoré | |||
| Frédéric Dumont | |||
| Amine Souadka | |||
| P2860 | cites work | Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes | Q33627785 |
| Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis | Q33839525 | ||
| Metastases in carcinoma; analysis of 1000 autopsied cases | Q33981757 | ||
| Long-term survival after laparoscopic colon resection for cancer: complete five-year follow-up | Q34635092 | ||
| Perforated colorectal carcinomas | Q34735505 | ||
| Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma | Q35072953 | ||
| Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy | Q35693338 | ||
| Risk factors for peritoneal dissemination of colorectal cancer | Q35873451 | ||
| Surgical trauma and peritoneal recurrence of colorectal carcinoma | Q36005316 | ||
| A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum | Q36114502 | ||
| Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center | Q37586217 | ||
| Revised guidelines for second-look surgery in patients with colon and rectal cancer | Q37790166 | ||
| Management of obstructive and perforated colorectal cancer | Q37799827 | ||
| Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country | Q38480635 | ||
| Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival | Q39708489 | ||
| Ovarian metastasis from colorectal cancer | Q39745481 | ||
| Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study | Q39928697 | ||
| Prognostic factors in Japanese patients with colorectal cancer: the significance of large bowel obstruction--univariate and multivariate analyses | Q41903984 | ||
| The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. | Q42018593 | ||
| Prospective comparison of laparoscopic vs. open resections for colorectal adenocarcinoma over a ten-year period | Q42601022 | ||
| Perforative carcinoma of colon and rectum | Q43532123 | ||
| The survival rate and prognostic factors in 26 perforated colorectal cancer patients | Q43820099 | ||
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
| 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer | Q43941230 | ||
| Assessment of clinicopathologic features of colorectal mucinous adenocarcinoma | Q44052969 | ||
| Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum | Q44075261 | ||
| Prognostic value of peritoneal cytology and the combination of peritoneal cytology and peritoneal dissemination in colorectal cancer | Q44115317 | ||
| Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study | Q44393228 | ||
| Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population | Q45050066 | ||
| Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. | Q50522604 | ||
| Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer. | Q51843144 | ||
| Randomized clinical trial of Ligasure versus conventional diathermy for day-case haemorrhoidectomy. | Q52861774 | ||
| SURVIVAL RATE IN OBSTRUCTING CARCINOMA OF COLON. | Q53040308 | ||
| Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
| Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. | Q53472724 | ||
| Role of surgery in the treatment of ovarian metastases from colorectal cancer. | Q53498043 | ||
| Laparoscopic resection of rectal cancer: a comparison of surgical and oncologic outcomes between extraperitoneal and intraperitoneal disease locations. | Q53547082 | ||
| Significance of signet-ring cells in patients with colorectal cancer. | Q53557104 | ||
| Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. | Q53864336 | ||
| Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. | Q54621338 | ||
| Peculiarities of mucinous colorectal carcinoma | Q58261600 | ||
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| systematic review | Q1504425 | ||
| peritoneal carcinomatosis | Q2071182 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 183-192 | |
| P577 | publication date | 2012-10-23 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review | |
| P478 | volume | 20 |
| Q56343872 | 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation |
| Q55375912 | Adenocarcinoma of the Colon Disguised as Abdominal Wall Abscess: Case Report and Review of the Literature. |
| Q50086170 | An Unusual Progression of Signet-Ring Cell Carcinoma of the Appendix in a Caucasian Woman |
| Q51825453 | Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. |
| Q41612691 | Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives. |
| Q42181455 | Colorectal cancer: prevention and management of metastatic disease |
| Q92323504 | Colorectal peritoneal metastases: Optimal management review |
| Q55258604 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. |
| Q50002298 | Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations |
| Q49291015 | HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma |
| Q38661645 | Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques |
| Q90599804 | Individualized multimodal treatment strategy for metastatic rectal adenocarcinoma: Case report |
| Q41964894 | Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer |
| Q53241191 | Insertion of a Stent in Obstructive Colon Cancer Can Induce a Metastatic Process in an Experimental Murine Model. |
| Q26829874 | Intra-operative peritoneal lavage for colorectal cancer |
| Q39014341 | Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review |
| Q35678364 | Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review |
| Q47117310 | Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases |
| Q54308984 | Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. |
| Q38219220 | Management of peritoneal carcinomatosis from colorectal cancer: review of the literature |
| Q26769938 | Multimodality treatment strategies have changed prognosis of peritoneal metastases |
| Q38765795 | Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer? |
| Q90618560 | Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study |
| Q97894912 | PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases |
| Q28073129 | Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum |
| Q89047880 | Peritoneal Metastases from Gastrointestinal Cancer |
| Q39810853 | Peritoneal Metastases: Prevention and Treatment |
| Q45917079 | Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors. |
| Q92861533 | Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review |
| Q101353630 | Results from the PROPHYLOCHIP-PRODIGE 15 trial - Authors' reply |
| Q55424667 | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer. |
| Q42324105 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives? |
| Q97894909 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study |
| Q52952846 | Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution. |
| Q92716708 | Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q30239825 | Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer |
| Q97525355 | Surgical management of recurrent colon cancer |
| Q26768405 | Surgical technology and pharmacology of hyperthermic perioperative chemotherapy |
| Q38780368 | Surveillance after curative treatment for colorectal cancer |
| Q90319513 | Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer |
| Q46596474 | The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer |
| Q41218475 | The role of surgical excision for the Krukenberg tumour: A case report |
| Q26744031 | Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives |
Search more.